The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $45.12

Today's change+0.73 +1.64%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $45.12

Today's change+0.73 +1.64%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc Hits New 52-week High

Baxter International Inc closed up sharply Wednesday, rallying (U.S.)$0.73 or 1.64% to (U.S.)$45.12 and setting a new 52-week high. Over the last five days, shares have gained 2.13% and 18.27% year to date. Shares have underperformed the S&P 500 by 32.49% during the last year.

Key company metrics

  • Open(U.S.) $44.27
  • Previous close(U.S.) $44.39
  • High(U.S.) $45.25
  • Low(U.S.) $44.15
  • Bid / Ask(U.S.) $45.00 / (U.S.) $45.57
  • YTD % change+18.27%
  • Volume15,992,992
  • Average volume (10-day)13,454,909
  • Average volume (1-month)7,376,984
  • Average volume (3-month)5,838,077
  • 52-week range(U.S.) $32.18 to (U.S.) $72.84
  • Beta0.64
  • Trailing P/E7.42×
  • P/E 1 year forward27.06×
  • Forward PEG2.33×
  • Indicated annual dividend(U.S.) $0.52
  • Dividend yield1.15%
  • Trailing EPS(U.S.) $6.08
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.55%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,3752,6032,4873,893
Total other revenue--------
Total revenue2,3752,6032,4873,893
Gross profit9651,0521,0491,926
Total cost of revenue1,4101,5511,4381,967
Total operating expense2,1872,1882,5253,458
Selling / general / administrative641672670951
Research & development136158140292
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)---193277248
Other operating expenses, total--------
Operating income188415-38435
Interest income (expense), net non-operating---37-38-40
Gain (loss) on sale of assets--------
Other--------
Income before tax3,329205-33468
Income after tax3,3871832336
Income tax, total-5822-35132
Net income3,3802051332
Total adjustments to net income--------
Net income before extra. items3,3871832336
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,3871832336
Inc. avail. to common incl. extra. items3,3802051332
Diluted net income3,3802051332
Dilution adjustment--------
Diluted weighted average shares552552549549
Diluted EPS excluding extraordinary itemsvalue per share6.140.330.000.61
Dividends per sharevalue per share0.120.120.120.52
Diluted normalized EPSvalue per share6.290.020.341.00